Dalbergia Consulting Limited is a limited company established in 2015, specializing in strategic consulting for esophageal cancer patients and their families. Based in Burmor House, Market Deeping, PE6 8FD, the company operates with a focus on enhancing patient outcomes and facilitating access to vital resources. Dalbergia’s core services encompass data analysis, market research, and strategic planning tailored to the unique challenges faced by individuals diagnosed with esophageal cancer. The company’s expertise lies in interpreting complex medical data, identifying emerging trends, and providing actionable insights to optimize treatment pathways. Dalbergia’s team comprises experienced consultants with a deep understanding of oncology, pharmaceutical developments, and patient advocacy. Currently, Dalbergia Consulting Limited is classified as a Skilled Worker, holding a Worker (A) rating. The company’s international presence is currently limited, focusing primarily on the UK market. Dalbergia’s key focus is on providing bespoke consulting solutions to support patients and their families through the complexities of esophageal cancer care. The company is actively seeking to expand its international reach and strategic partnerships. SIC Codes include: - 74902: Quantity surveying activities, - 74911: Medical and health services advisory services, - 74912: Pharmaceutical and medical device advisory services, - 74931: Clinical research and data management services.

Dalbergia Consulting Limited is a limited company established in 2015, specializing in strategic consulting for esophageal cancer patients and their families. Based in Burmor House, Market Deeping, PE6 8FD, the company operates with a focus on enhancing patient outcomes and facilitating access to vital resources. Dalbergia’s core services encompass data analysis, market research, and strategic planning tailored to the unique challenges faced by individuals diagnosed with esophageal cancer. The company’s expertise lies in interpreting complex medical data, identifying emerging trends, and providing actionable insights to optimize treatment pathways. Dalbergia’s team comprises experienced consultants with a deep understanding of oncology, pharmaceutical developments, and patient advocacy. Currently, Dalbergia Consulting Limited is classified as a Skilled Worker, holding a Worker (A) rating. The company’s international presence is currently limited, focusing primarily on the UK market. Dalbergia’s key focus is on providing bespoke consulting solutions to support patients and their families through the complexities of esophageal cancer care. The company is actively seeking to expand its international reach and strategic partnerships. SIC Codes include: - 74902: Quantity surveying activities, - 74911: Medical and health services advisory services, - 74912: Pharmaceutical and medical device advisory services, - 74931: Clinical research and data management services.